Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umesh Nair

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Annals of Translational Medicine|November 4, 2021
Kv3.1 channelopathy: a novel loss-of-function variant and the mechanistic basis of its clinical phenotypesXiaoyang Li, Yongsheng Zheng, Shaoyuan Li, et al.
Epilepsia|September 6, 2018
Lack of response to quinidine in KCNT1-related neonatal epilepsyAdam L Numis, Umesh Nair, Anita N Datta, et al.
Neurology|December 3, 2017
Precision therapy for epilepsy due to <i>KCNT1</i> mutations: A randomized trial of oral quinidineSaul A Mullen, Patrick W Carney, Annie Roten, et al.
Neurology|April 1, 2016
A targeted resequencing gene panel for focal epilepsyMichael S Hildebrand, Candace T Myers, Gemma L Carvill, et al.
Annals of Neurology|March 5, 2014
KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidineCarol J Milligan, Melody Li, Elena V Gazina, et al.
Annals of Clinical and Translational Neurology|July 30, 2019
Encephalopathies with KCNC1 variants: genotype-phenotype-functional correlationsJillian M Cameron, Snezana Maljevic, Umesh Nair, et al.
Neurology|December 3, 2017
Clinical and molecular characterization of <i>KCNT1</i>-related severe early-onset epilepsyAmy McTague, Umesh Nair, Sony Malhotra, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Annals of Translational Medicine|November 4, 2021
Kv3.1 channelopathy: a novel loss-of-function variant and the mechanistic basis of its clinical phenotypesXiaoyang Li, Yongsheng Zheng, Shaoyuan Li, et al.
Epilepsia|September 6, 2018
Lack of response to quinidine in KCNT1-related neonatal epilepsyAdam L Numis, Umesh Nair, Anita N Datta, et al.
Neurology|December 3, 2017
Precision therapy for epilepsy due to <i>KCNT1</i> mutations: A randomized trial of oral quinidineSaul A Mullen, Patrick W Carney, Annie Roten, et al.
Neurology|April 1, 2016
A targeted resequencing gene panel for focal epilepsyMichael S Hildebrand, Candace T Myers, Gemma L Carvill, et al.
Annals of Neurology|March 5, 2014
KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidineCarol J Milligan, Melody Li, Elena V Gazina, et al.
Annals of Clinical and Translational Neurology|July 30, 2019
Encephalopathies with KCNC1 variants: genotype-phenotype-functional correlationsJillian M Cameron, Snezana Maljevic, Umesh Nair, et al.
Neurology|December 3, 2017
Clinical and molecular characterization of <i>KCNT1</i>-related severe early-onset epilepsyAmy McTague, Umesh Nair, Sony Malhotra, et al.
Pageof 1